Hemorrhoidal Suppository
NDC 59779-279
Product Information
Hemorrhoidal (cocoa butter, phenylephrine hcl) is a OTC MONOGRAPH DRUG-approved product labeled by Cvs Pharmacy. This medication is typically used as a adrenergic alpha1-agonists [moa]. It is supplied as a yellow suppository for rectal administration. This product entry covers the primary NDC 59779-279 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 59779-279?
What are the uses of this product?
What are Active Ingredients of this product?
- COCOA BUTTER 2211 mg/1 - predominantly saturated fat; RN given refers to parent cpd
- PHENYLEPHRINE HYDROCHLORIDE 6.5 mg/1 - An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- COCOA BUTTER (UNII: 512OYT1CRR)
- COCOA BUTTER (UNII: 512OYT1CRR) (Active Moiety)
- PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ)
- PHENYLEPHRINE (UNII: 1WS297W6MV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- STARCH, CORN (UNII: O8232NY3SJ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1438497 - cocoa butter 88.4 % / phenylephrine HCl 0.25 % Rectal Suppository
- RxCUI: 1438497 - cocoa butter 0.884 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.